You are here

Technology for Clinical Management of Oxidative Stress

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 MH53810-01,
Agency Tracking Number: 29596
Amount: $748,741.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 1997
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
45 Wiggins Avenue
Bedford, MA 01730
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Wayne Matson
 () -
Business Contact
Phone: () -
Research Institution

We will develop technology for assessing and managing oxidative stress in neurodegenerative disordePhase I aims are defining urine plasma levels of twelve proposed purine, hydroxyl, and nitrohydroxyspectrum of neurodegenerative diseases; evaluating challenge tests for over production and under prooxygen species; investigating simplified sample acquisition analysis protocols for clinical laboratoapplying new electrochemical technology for monitoring oxidative capacity. Methodology for existingElectrode Array Systems (CEAS) with new adjunct technology for contaminant suppression and reactivestabilization allows simultaneous resolution of twelve currently proposed oxidative stress markers foxidizable species. Unique properties of treated porous graphites allow the potential simplificatioacquisition and assay and an integrated sampler sensor disposable derived from blood lead analysis tused to measure total oxidative capacity. The works technical and commercial significance lies in detechnological improvements in chromatographic methodology for the research market; broadening the apintegrated sampler/sensor technology for on site monitoring and a new disposable kit and assay for tlaboratory market.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government